Astrophic Vaginitis & Vaginal Atrophy : Symptoms, Causes and Care Options
Causes · Symptoms · GSM & Bladder Issues · Prolapse vs. Atrophy · Care Options · Pelvic Floor Therapy
Atrophic vaginitis and vaginal atrophy describe the same underlying change, just from two different angles — one names the inflammation that often comes with it, the other names the tissue change itself. It is coming to light that over 60% of women will experience these symptoms, which shows this is far more common than the silence around them suggests.
What Is Atrophic Vaginitis?
As estrogen declines, vaginal tissue grows thinner, drier, less elastic, and more prone to irritation and inflammation — atrophic vaginitis is the term for this tissue becoming inflamed and irritated as a result.
Clinicians now often use a broader term genitourinary syndrome of menopause (GSM), since the same estrogen decline affects urinary tissue and function too, not just vaginal comfort.
Causes
Menopause is the most common cause, but it isn't the only one:
- Natural menopause — the primary cause, as ovarian estrogen production declines.
- Surgical menopause — removal of the ovaries causes a sudden estrogen drop rather than a gradual one, often making symptoms more abrupt and pronounced.
- Breastfeeding — suppresses estrogen temporarily, which can cause similar symptoms even in younger women.
- Cancer treatment — particularly aromatase inhibitors used in breast cancer treatment, and other therapies that suppress estrogen.
- Certain medications — including some fertility treatments and anti-estrogen medications.
Symptoms
- Vaginal dryness, burning, or itching
- Tissue discomfort when sitting on hard surfaces
- Discomfort or pain during intercourse
- Mild bleeding or spotting after intercourse
- A shortening or narrowing of the vaginal canal over time
- Increased frequency of urinary tract infections
- Urinary urgency or discomfort with urination
- A general sense of tissue feeling more fragile or less elastic than before
Symptoms usually build gradually, which is part of why so many women don't connect them to menopause until they're asked directly by a provider. Even more, many younger women can experience these symptoms and not realize that something is off.
How GSM and Bladder Issues Are Linked
This connection surprises a lot of women: the same estrogen receptors found in vaginal tissue are also present throughout the urethra and bladder lining. When estrogen declines, that tissue thins and weakens right alongside vaginal tissue, which is exactly why GSM includes urinary symptoms as a core part of the condition rather than a separate, unrelated issue.
This shows up as more frequent UTIs, a more urgent or frequent need to urinate, and sometimes mild urinary leakage. It's also part of why treating GSM — whether through vaginal estradiol, DHEA, or another approach — often improves bladder symptoms too, since both tissues are responding to the same underlying hormonal cause.
Prolapse vs. Atrophy: Are They the Same Thing?
These two get confused constantly, and they're genuinely different conditions with different primary causes, even though they often show up in the same women at the same life stage.
Vaginal atrophy is a tissue-quality problem — the vaginal walls themselves become thinner and less elastic due to declining estrogen. Pelvic organ prolapse is a structural, mechanical problem — the muscles and connective tissue that support the bladder, uterus, or rectum weaken or stretch, allowing one or more of these organs to shift downward or press into the vaginal canal. Prolapse is driven primarily by childbirth history, chronic straining, and age-related connective tissue changes, rather than estrogen decline directly — though menopause-related tissue changes can worsen prolapse symptoms once it's present.
Can prolapse happen later, even years after childbirth? Yes — this is actually the more common pattern, not the exception. Pelvic floor support can weaken gradually over decades, and menopause-related changes in tissue elasticity often bring prolapse symptoms to the surface later in life, even when the initial strain happened during childbirth many years earlier. This is one of the more common reasons women first notice prolapse symptoms in their 50s or 60s rather than immediately postpartum.
Care Options
The most direct, highly researched treatment for the tissue-level changes of atrophic vaginitis is local vaginal estradiol, working through genuine estrogen receptor activation to restore tissue health. Vaginal DHEA and oral ospemifene offer related, non-estrogen prescription routes.
Some women may not prefer to have added hormones though, as especially estrogen sensitive individuals can experience side effects. Alternatively, you can also use an herbal-based option such as our Vital Vulva Vaginal Moisturizer which is known to help women with these changes without added hormones.
For daily comfort — dryness, friction, irritation — a moisturizer built on repair-supportive botanicals like comfrey, or sea buckthorn oil genuinely helps ease symptoms and supports the skin's own healing response. Our full Estradiol Alternatives guide breaks down every option in more depth, including a full ingredient-by-ingredient comparison of what different botanicals are actually documented to do.
Pelvic Floor Therapy May Be Beneficial
This is genuinely one of the most underused options in this entire picture, mostly because it's a specialty rather than a product you can order. A pelvic floor physical therapist addresses the muscular and structural side of both prolapse and general pelvic comfort directly — strengthening and coordinating the muscles that support pelvic organs, which can meaningfully help both prolapse-related symptoms and the general comfort and elasticity side of atrophic changes. It's a helpful complement to whichever treatment path you choose for the tissue-level side of things, not a replacement for it.
This information is educational and not a substitute for medical advice. Talk to your healthcare provider about your specific symptoms, especially if you're noticing signs of prolapse or significant tissue changes.
